Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex

Virus Research

Volumn 124, Issue 1-2, 2007, Pages 103-112

  Welman, Mélanie ^a   Lemay, Guy ^a   Cohen, Éric A ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Envelope glycoproteins; Envelope processing; Envelope trimer; gp41; gp41 membrane spanning domain; HIV; Viral fusion

Indexed keywords

GLYCOPROTEIN GP 41; INFLUENZA VIRUS HEMAGGLUTININ; ISOLEUCINE; MEMBRANE PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING; VIRUS INFECTIVITY; VIRUS PARTICLE;

CELL LINE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HIV ENVELOPE PROTEIN GP160; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; RECOMBINATION, GENETIC; SEQUENCE DELETION; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846861789     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2006.10.009     Document Type: Article

References (52)

1. Bewley C.A., Louis J.M., Ghirlando R., and Clore G.M. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41. J. Biol. Chem. 277 16 (2002) 14238-14245
2. Cavrois M., De Noronha C., and Greene W.C. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20 11 (2002) 1151-1154
3. Chan D.C., Chutkowski C.T., and Kim P.S. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc. Natl. Acad. Sci. U.S.A. 95 26 (1998) 15613-15617
4. Chan D.C., and Kim P.S. HIV entry and its inhibition. Cell 93 5 (1998) 681-684
5. Cleverley D.Z., and Lenard J. The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc. Natl. Acad. Sci. U.S.A. 95 7 (1998) 3425-3430
6. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W., and Coico R. Current Protocols in Immunology (2000), John Wiley and Sons, Inc., New York, NY p. 12.15.18
7. Colman P.M., and Lawrence M.C. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell. Biol. 4 4 (2003) 309-319
8. Decroly E., Vandenbranden M., Ruysschaert J.M., Cogniaux J., Jacob G.S., Howard S.C., Marshall G., Kompelli A., Basak A., Jean F., et al. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J. Biol. Chem. 269 16 (1994) 12240-12247
9. Doms R.W., Lamb R.A., Rose J.K., and Helenius A. Folding and assembly of viral membrane proteins. Virology 193 2 (1993) 545-562
10. Dorfman T., Mammano F., Haseltine W.A., and Gottlinger H.G. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68 3 (1994) 1689-1696
11. Dubay J.W., Dubay S.R., Shin H.J., and Hunter E. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 69 8 (1995) 4675-4682
12. Earl P.L., Moss B., and Doms R.W. Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein. J. Virol. 65 4 (1991) 2047-2055
13. Eckert D.M., and Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70 (2001) 777-810
14. Fujiwara T., Oda K., Yokota S., Takatsuki A., and Ikehara Y. Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J. Biol. Chem. 263 34 (1988) 18545-18552
15. Furuta R.A., Wild C.T., Weng Y., and Weiss C.D. Capture of an early fusion-active conformation of HIV-1 gp41. Nat. Struct. Biol. 5 4 (1998) 276-279
16. Gabuzda D.H., Lever A., Terwilliger E., and Sodroski J. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 66 6 (1992) 3306-3315
17. Gallo S.A., Clore G.M., Louis J.M., Bewley C.A., and Blumenthal R. Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41. Biochemistry 43 25 (2004) 8230-8233
18. Herrera C., Klasse P.J., Kibler C.W., Michael E., Moore J.P., and Beddows S. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex. Virology 351 1 (2006) 121-132
19. Herrera C., Klasse P.J., Michael E., Kake S., Barnes K., Kibler C.W., Campbell-Gardener L., Si Z., Sodroski J., Moore J.P., and Beddows S. The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles. Virology 338 1 (2005) 154-172
20. Iwatani Y., Kawano K., Ueno T., Tanaka M., Ishimoto A., Ito M., and Sakai H. Analysis of dominant-negative effects of mutant Env proteins of human immunodeficiency virus type 1. Virology 286 1 (2001) 45-53
21. Jacobs A., Sen J., Rong L., and Caffrey M. Alanine scanning mutants of the HIV gp41 loop. J. Biol. Chem. 280 29 (2005) 27284-27288
22. Kemble G.W., Danieli T., and White J.M. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell 76 2 (1994) 383-391
23. Kimpton J., and Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene. J. Virol. 66 4 (1992) 2232-2239
24. Kinomoto M., Yokoyama M., Sato H., Kojima A., Kurata T., Ikuta K., Sata T., and Tokunaga K. Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor. J. Virol. 79 10 (2005) 5996-6004
25. Kyte J., and Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157 1 (1982) 105-132
26. Levesque K., Zhao Y.S., and Cohen E.A. Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1-producing cells. J. Biol. Chem. 278 30 (2003) 28346-28353
27. Lin S., Naim H.Y., Rodriguez A.C., and Roth M.G. Mutations in the middle of the transmembrane domain reverse the polarity of transport of the influenza virus hemagglutinin in MDCK epithelial cells. J. Cell. Biol. 142 1 (1998) 51-57
28. Liu J., Shu W., Fagan M.B., Nunberg J.H., and Lu M. Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion. Biochemistry 40 9 (2001) 2797-2807
29. Lodge R., Gottlinger H., Gabuzda D., Cohen E.A., and Lemay G. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68 8 (1994) 4857-4861
30. Lodge R., Lalonde J.P., Lemay G., and Cohen E.A. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells. EMBO J. 16 4 (1997) 695-705
31. Lu M., Stoller M.O., Wang S., Liu J., Fagan M.B., and Nunberg J.H. Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis. J. Virol. 75 22 (2001) 11146-11156
32. Melikyan G.B., Markosyan R.M., Roth M.G., and Cohen F.S. A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion. Mol. Biol. Cell. 11 11 (2000) 3765-3775
33. Melikyan G.B., White J.M., and Cohen F.S. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J. Cell. Biol. 131 3 (1995) 679-691
34. Miyauchi K., Komano J., Yokomaku Y., Sugiura W., Yamamoto N., and Matsuda Z. Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J. Virol. 79 8 (2005) 4720-4729
35. Odell D., Wanas E., Yan J., and Ghosh H.P. Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G. J. Virol. 71 10 (1997) 7996-8000
36. Ragheb J.A., and Anderson W.F. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J. Virol. 68 5 (1994) 3207-3219
37. Salzwedel K., and Berger E.A. Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41. Proc. Natl. Acad. Sci. U.S.A. 97 23 (2000) 12794-12799
38. Salzwedel K., Johnston P.B., Roberts S.J., Dubay J.W., and Hunter E. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 67 9 (1993) 5279-5288
39. Schroth-Diez B., Ludwig K., Baljinnyam B., Kozerski C., Huang Q., and Herrmann A. The role of the transmembrane and of the intraviral domain of glycoproteins in membrane fusion of enveloped viruses. Biosci. Rep. 20 6 (2000) 571-595
40. Terwilliger E.F., Cohen E.A., Lu Y.C., Sodroski J.G., and Haseltine W.A. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. U.S.A. 86 13 (1989) 5163-5167
41. Tobiume M., Lineberger J.E., Lundquist C.A., Miller M.D., and Aiken C. Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J. Virol. 77 19 (2003) 10645-10650
42. Ulmschneider M.B., and Sansom M.S. Amino acid distributions in integral membrane protein structures. Biochim. Biophys. Acta 1512 1 (2001) 1-14
43. Upender M., Raj L., and Weir M. Megaprimer method for in vitro mutagenesis using parallel templates. Biotechniques 18 1 (1995) 29-30 32
44. Wang S., York J., Shu W., Stoller M.O., Nunberg J.H., and Lu M. Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion. Biochemistry 41 23 (2002) 7283-7292
45. Weiss C.D., and White J.M. Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 67 12 (1993) 7060-7066
46. Weng Y., and Weiss C.D. Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 72 12 (1998) 9676-9682
47. Wild C., Greenwell T., and Matthews T. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses 9 11 (1993) 1051-1053
48. Wild C., Oas T., McDanal C., Bolognesi D., and Matthews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. U.S.A. 89 21 (1992) 10537-10541
49. Wilk T., Pfeiffer T., Bukovsky A., Moldenhauer G., and Bosch V. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain. Virology 218 1 (1996) 269-274
50. Wyatt R., and Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280 5371 (1998) 1884-1888
51. Yao X.J., Friborg J., Checroune F., Gratton S., Boisvert F., Sekaly R.P., and Cohen E.A. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha-helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology 209 2 (1995) 615-623
52. Yao X.J., Gottlinger H., Haseltine W.A., and Cohen E.A. Envelope glycoprotein and CD4 independence of vpu-facilitated human immunodeficiency virus type 1 capsid export. J. Virol. 66 8 (1992) 5119-5126